<DOC>
	<DOCNO>NCT00317460</DOCNO>
	<brief_summary>The purpose study examine efficacy provide two level psychosocial support along buprenorphine/naloxone ( BUP ) maintenance opioid dependent patient receive care HIV clinical care set .</brief_summary>
	<brief_title>Buprenorphine Integrated HIV Care</brief_title>
	<detailed_description>The purpose study examine efficacy provide two level psychosocial support along buprenorphine/naloxone ( BUP ) maintenance opioid dependent patient receive care HIV clinical care set . The propose study compare Physician Management ( PM ) , manual-guided brief intervention approximate usual counseling provide primary care practitioner patient chronic medical condition vs. enhance strategy PM addition combine drug counsel adherence management strategy ( PM+DC/AM ) . DC design educate patient recovery process provide additional advice lifestyle change include HIV transmission risk reduction 12-step participation . Adherence Management ( AM ) counseling strategy focus HIV medication adherence , adapt Sorensen et al1 . This research build pilot work complete order develop refine counsel intervention , determine psychosocial intervention might require , evaluate model integrate care term effect opioid agonist therapy retention , decrease illicit drug use , increase adherence highly active antiretroviral therapy ( HAART ) . Finally , provide data aid formulation guideline creation practical manual optimize provision novel therapy individual HIV disease opioid dependence , well provide data future fund randomized clinical trial . From September 2005 ( start date ) December 1 , 2007 , study conduct part multi-site project overseen New York Academy Medicine ( NYAM ) , charge data analysis . Following December 1 , 2007 , study continue local , single-site project without collaboration NYAM .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Behavior , Addictive</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<criteria>HIV disease DSMIV criterion opioid dependence , assess SCID Documented opioid positive urine toxicology test Exclusion criterion : Desire remain enrolled opioid agonist treatment opioid treatment program Current dependence alcohol , benzodiazepine sedative ( patient receive benzodiazepine care psychiatrist treatment anxiety disorder exclude ) Current suicide homicide risk Current psychotic disorder major depression Inability read understand English Dementia Lifethreatening unstable medical problem require inpatient medical care nursing home placement Currently enrol study involve provision psychosocial treatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Drug Abuse</keyword>
	<keyword>Drug Addiction</keyword>
	<keyword>Drug Dependence</keyword>
	<keyword>Drug Use Disorders</keyword>
	<keyword>Drug Use Disorder</keyword>
	<keyword>Substance Abuse</keyword>
	<keyword>Substance Use Disorder</keyword>
	<keyword>Buprenorphine</keyword>
	<keyword>Opiate Addiction</keyword>
</DOC>